HUAXI Securities·2025-09-02 11:25Investment Rating - The investment rating for Fosun International is "Buy" [1] Core Views - Fosun International's core industries are operating steadily, and the RWA ecological layout is progressing steadily. The company reported a total revenue of 87.3 billion yuan in the first half of 2025, a year-on-year decrease of 10.8% [2]. - The company is focusing on local and international dual-driven strategies in its insurance segment, with total premium income of 3.27 billion euros in the first half of 2025, an increase of 16.5% year-on-year [3]. - The company has made significant advancements in its RWA ecological layout, obtaining licenses for virtual assets and launching a leading RWA platform [4][5]. - Fosun Pharma's innovative drug revenue is steadily growing, with a revenue of over 4.3 billion yuan, a year-on-year increase of 14.26% [6][7]. - The performance of core subsidiary Yuyuan Inc. showed improvement in Q2, with revenue of 19.11 billion yuan, a year-on-year decrease of 30.68% [8]. Summary by Sections Financial Performance - In the first half of 2025, Fosun International's total revenue was 87.3 billion yuan, with a net profit of 660 million yuan, a year-on-year decrease of 8.2% [2]. - The company adjusted its revenue forecasts for 2025-2026 to 96 billion and 103.4 billion yuan, respectively, with net profit estimates of 730 million and 930 million yuan [9]. Insurance Segment - Fosun Portugal Insurance's total premium income reached 3.27 billion euros, with a market share of 29.3% in Portugal [3]. - The international business of Fosun Portugal Insurance reported a premium income of 920 million euros, a year-on-year increase of 4.3% [3]. RWA Ecological Layout - The company has obtained licenses for virtual asset trading and investment management, enhancing its capabilities in the RWA sector [4][5]. Pharmaceutical Segment - Fosun Pharma's revenue was 19.426 billion yuan, with a net profit of 1.702 billion yuan, a year-on-year increase of 38.94% [6][7]. Subsidiary Performance - Yuyuan Inc. reported a revenue of 19.112 billion yuan in Q2, with a significant improvement in operational cash flow [8].